You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 20, November 13, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diabetes Mellitus
 •Evidence-Based Medicine
 •Hypertension
 •Neurology
 •Prognosis/ Outcomes
 •Adverse Effects
 •Alert me on articles by topic

New-Onset Diabetes Mellitus Less Deadly Than Elevated Blood Pressure?

Following the Evidence in the Administration of Thiazide Diuretics

Arch Intern Med. 2006;166:2174-2176.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The day a physician loses his humility is the day that physician becomes a menace to society.—Richard Gorlin, MD

The primary outcome analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)1 demonstrated that first-step therapy with a thiazide diuretic was equally effective in reducing major cardiovascular events compared with either a calcium channel blocker (CCB) or angiotensin-converting enzyme (ACE) inhibitor. The results did not bring joy to the pharmaceutical industry, academicians with excessively close ties to the industry, or hypertension specialists wedded to the importance of renin-angiotensin system blockade. The report from the ALLHAT trial in this issue of the ARCHIVES2 will not bring solace to any of these groups. In this retrospective analysis, ALLHAT investigators demonstrate that patients with hypertension who develop diabetes mellitus (DM) while taking thiazide fare better than those who develop DM undergoing treatment with a CCB or ACE inhibitor. . . . [Full Text of this Article]


AUTHOR INFORMATION
Robert A. Phillips, MD, PhD


RELATED ARTICLE

Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Joshua I. Barzilay, Barry R. Davis, Jeffrey A. Cutler, Sara L. Pressel, Paul K. Whelton, Jan Basile, Karen L. Margolis, Stephen T. Ong, Laurie S. Sadler, John Summerson, and for the ALLHAT Collaborative Research Group
Arch Intern Med. 2006;166(20):2191-2201.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute
Carter et al.
Hypertension 2008;52:30-36.
FULL TEXT  

What If Chlorthalidone-Associated Hyperglycemia Develops?
Silver
Arch Intern Med 2007;167:1434-1434.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.